Home › Funds › Farallon Capital Management › ALKS
Farallon Capital Management position in ALKS
ALKERMES PLC · Health Care
Latest position (Q1 2026)20.80K sh
Reported value held$735.49K
Portfolio Weight0.00%
First reportedQ1 2025
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 1.39M | $45.89M | New |
| Q2 2025 | 691.66K | $19.79M | Reduce |
| Q3 2025 | 20.80K | $624.00K | Reduce |
| Q4 2025 | 20.80K | $581.98K | Hold |
| Q1 2026 | 20.80K | $735.49K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALKS
- BlackRock Inc 29.24M sh · $1.53B · Q2 2026
- Vanguard Group 18.01M sh · $503.85M · Q4 2025
- Renaissance Technologies 6.46M sh · $338.52M · Q2 2026
- Geode Capital Management 4.48M sh · $234.66M · Q2 2026
- Wellington Management Group 2.81M sh · $147.48M · Q2 2026
- Charles Schwab Investment Management 2.34M sh · $122.35M · Q2 2026
- Norges Bank Investment Management 2.16M sh · $113.01M · Q2 2026
- Goldman Sachs Group 2.02M sh · $106.05M · Q2 2026
- Citadel Advisors 1.89M sh · $99.13M · Q2 2026
- Northern Trust Corp 1.83M sh · $95.97M · Q2 2026
- Morgan Stanley 1.75M sh · $91.79M · Q2 2026
- D. E. Shaw & Co 1.31M sh · $68.74M · Q2 2026